Independent report

Prioritising the first COVID-19 vaccine dose: JCVI statement

Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about increasing the short-term impact of the COVID-19 vaccination programme.

Documents

Annex A: PHE report to JCVI on estimated efficacy of a single dose of Pfizer BioNTech (BNT162b2 mRNA) vaccine and of a single dose of ChAdOx1 vaccine (AZD1222)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Annex B: comparison between 1 and 2 dose prioritisation for a fixed number of doses

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Updates to this page

Published 6 January 2021
Last updated 26 January 2021 + show all updates
  1. Added document 'Annex B: comparison between 1 and 2 dose prioritisation for a fixed number of doses'.

  2. First published.

Sign up for emails or print this page